Gerit-Holger Schernthaner

Advanced search ?

Discover the optimal journal based on multiple criteria or locate authors along with their published articles and the corresponding journals.

Publisher

* You can search a publisher or tap the name directly

Subject Area

* You can search a subject area or tap the name directly

Open Acess

Yes

Quartille

Q1
Q3

Q2
Q4

You can also search
by the journal's Country or the impact indicator H-index.

Countries

* You can search a country or tap the name directly

H-Index

* You can also filter by Journal H-index

17 Publications

Publication								Year
Non-esterified fatty acids: Another piece in the puzzle of PAD risk stratification? Authors : Bernhard Zierfuss , Herbert Stangl , Gerit-Holger Schernthaner Journal : Atherosclerosis Journal Reference count : 13 Volume : 370 Pages : 1-2								2023
The right place for metformin today Authors : Guntram Schernthaner , Gerit-Holger Schernthaner Journal : Diabetes Research and Clinical Practice Journal Reference count : 74 Volume : 159 Pages : 107946								2020
How many more data is required to give the kidney the attention it deserves? Time to act for the “Big Five” of cardiovascular risk Authors : Florian Kronenberg , Gerit-Holger Schernthaner Journal : Atherosclerosis Journal Reference count : 20 Volume : 297 Pages : 146-148								2020
The enigma to best screen, evaluate and diagnose peripheral artery disease Authors : Gerald Seinost , Clemens HÖBAUS , Gerit-Holger Schernthaner Journal : Atherosclerosis Journal Reference count : 4 Volume : 315 Pages : 79-80								2020
New horizons for mortality risk stratification in PAD: Are targeted multiplex proteomics the next step? Authors : Bernhard Zierfuss , Christoph Neumayer , Gerit-Holger Schernthaner Journal : Atherosclerosis Journal Reference count : 6 Volume : 311 Pages : 98-99								2020
Finally, the big picture of morbidity and mortality in peripheral arterial disease? Authors : Bernhard Zierfuss , Mariella Catalano , Gerit-Holger Schernthaner Journal : Atherosclerosis Journal Reference count : 13 Volume : 293 Pages : 92-93								2020
sCD40L: An overestimated marker for cardiovascular risk prediction? Authors : Gerfried Pesau , Gerit-Holger Schernthaner Journal : Atherosclerosis Journal Reference count : 8 Volume : 291 Pages : 122-123								2019
YKL-40: an innocent bystander or an active threat in acute and chronic cardiac diseases? Authors : Gerit‑Holger Schernthaner , Clemens Höbaus Journal : Polish Archives of Internal Medicine Volume : 128 Pages : 636-637								2018
EMPA-REG and Other Cardiovascular Outcome Trials of Glucose-lowering Agents: Implications for Future Treatment Strategies in Type 2 Diabetes Mellitus Authors : Guntram Schernthaner , Marie Helene Schernthaner-Reiter , Gerit-Holger Schernthaner Journal : Clinical Therapeutics Journal Reference count : 61 Volume : 38 Pages : 1288-1298								2016
Moderate alcohol consumption shifts to an atheroprotective phenotype: A glass of wine keeps atherosclerosis in check? Authors : Gerit-Holger Schernthaner , Carsten Herz , Herbert Stangl Journal : Atherosclerosis Journal Reference count : 5 Volume : 254 Pages : 305-306								2016
Do we need a new classification system for arteriosclerotic lesions in crural limb ischemia? Pros and Cons Authors : Clemens Höbaus , Carsten Herz , Gerit-Holger Schernthaner Journal : Atherosclerosis Journal Reference count : 12 Volume : 251 Pages : 493-494								2016
The effects of GLP-1 analogues, DPP-4 inhibitors and SGLT2 inhibitors on the renal system Authors : Guntram Schernthaner , Carl Erik Mogensen , Gerit-Holger Schernthaner Journal : Diabetes and Vascular Disease Research Journal Reference count : 99 Volume : 11 Pages : 306-323								2014
Diabetic nephropathy: new approaches for improving glycemic control and reducing risk Authors : Guntram Schernthaner , Gerit Holger Schernthaner Journal : Journal of Nephrology Volume : 26 Pages : 975-985								2013
Do We Still Need Pioglitazone for the Treatment of Type 2 Diabetes? A risk-benefit critique in 2013 Authors : Guntram Schernthaner , Craig J. Currie , Gerit-Holger Schernthaner Journal : Diabetes Care Journal Reference count : 59 Volume : 36 Pages : S155-S161								2013
Reduced adiponectin receptor signalling accelerates atherosclerosis and may worsen the outcome in type 2 diabetes mellitus – Another one of those missing links? Authors : Gerit-Holger Schernthaner , Herbert Stangl Journal : Atherosclerosis Journal Reference count : 10 Volume : 229 Pages : 30-31								2013
Glycemic targets and antidiabetic drug treatment in patients with chronic kidney disease (stages 3–5) Authors : Guntram Schernthaner , Angelo Avogaro , Gerit Holger Schernthaner Journal : Hot Topics in Diabetes								2013
Insulin Resistance and Inflammation in the Early Phase of Type 2 Diabetes: Potential for Therapeutic Intervention Authors : Gerit‐Holger Schernthaner , Guntram Schernthaner Journal : Scandinavian Journal of Clinical and Laboratory Investigation Journal Reference count : 75 Volume : 65 Pages : 30-40								2005

Research Support Chat

Gerit-holger schernthaner

17 Publications

Home

Indexing Services

Customer Service

Research Support Chat

Advanced search ?

You can also search by the journal's Country or the impact indicator H-index.

Gerit-holger schernthaner

17 Publications

You can also search
by the journal's Country or the impact indicator H-index.